Patterns of gene expression reveal a temporally orchestrated wound healing response in the injured spinal cord

Margaret J Velardo1, Corinna Burger, Philip R Williams

  • 1Department of Neuroscience, McKnight Brain Institute of the University of Florida, Gainesville, Florida 32610-0244, USA. velardo@mbi.ufl.edu

Insights

Spinal cord injury triggers complex molecular changes. This study reveals a conserved, orchestrated tissue repair process with a wound healing signature in different rat strains after injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genomics

Background:

  • Spinal cord injury (SCI) involves complex molecular cascades impacting cell survival and neurological function.
  • Understanding these molecular interactions is crucial for developing effective therapeutics.

Purpose of the Study:

  • To investigate functional interactions within transcriptional profiles post-SCI.
  • To assess transcript expression consistency across genetically diverse rat strains (athymic nude and Sprague Dawley) with varying immune responses.

Main Methods:

  • Utilized Affymetrix U34A rat genome GeneChip microarrays to analyze gene expression at SCI lesion sites (1-90 days post-injury).
  • Employed stringent statistical analyses to identify significant transcriptional changes and inter-strain gene expression differences.
  • Performed functional categorization of differentially expressed genes.

Main Results:

  • Identified 3638 significantly changed probe sets and 80 genes differing between rat strains.
  • Unveiled a common, overall tissue remodeling response across both strains.
  • Observed temporally distinct gene expression profiles correlated with microscopic and MRI-based repair indices.

Conclusions:

  • Characterized a novel, longitudinal perspective of the post-SCI response as a highly orchestrated tissue repair and remodeling process.
  • Highlighted a conserved cutaneous wound healing signature in the injured spinal cord across different rat strains.
  • Findings provide insights for developing cellular and pharmacological therapies for spinal cord repair and neuronal regeneration.